The future of precision medicine part 7: public engagement

The developments of the information age that have enabled the development of precision medicine have also led to the empowerment of patients, who are now, via the internet, able to access general medical information and cutting-edge research on their conditions in a way that would have been previously impossible even to imagine.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

‘Doing more with less’: In-house counsel on budgets and strategy

22 October 2025 Chuck Scholtz, head of IP at Verdiva Bio, shares the pressures of global filing strategies on tight budgets, why there’s no ‘right way’ to manage IP, and how to get the best results from external counsel relationships.

Biotechnology

An update on patenting in Ukraine, Russia and Eurasia

2 September 2025 Erik Viik of Papula-Nevinpat looks at the dynamics that international applicants need to be aware of to secure and manage their patent rights across the region.

Biotechnology

Synthego clears rival’s patents from CRISPR market at Fed Circ

12 June 2025 Judges uphold PTAB’s finding that two Agilent patents are invalid | All claims of patents, which cover guide RNAs, found to be anticipated by prior art.

More features

Orrick adds specialist licensing partner in Silicon Valley

Emotional Perception: What next for patent holders?

LSPN Awards 2026 finalists revealed

Natera and a rival draw the line under five-year fight

Eli Lilly escapes $278m payout in biotech licensing dispute

Wiggin’s new litigation partner deepens ‘technically complex’ offer

BioNTech fires shots at Moderna's next-generation vaccine

Mintz gains ex-Winston & Strawn partner and ITC expert

The future of precision medicine part 7: public engagement

More on this story

Editor's picks

Editor's picks

More features